Rowe CC - Search Results

1

MR-less surface-based amyloid estimation by subject-specific atlas selection and Bayesian fusion.

Zhou L, Salvado O, Dore V, Bourgeat P, Raniga P, Villemagne VL, Rowe CC, Fripp J; AIBL Research Group. Zhou L, et al. Among authors: rowe cc. Med Image Comput Comput Assist Interv. 2012;15(Pt 2):220-7. doi: 10.1007/978-3-642-33418-4_28. Med Image Comput Comput Assist Interv. 2012. PMID: 23286052

2

Imaginem oblivionis: the prospects of neuroimaging for early detection of Alzheimer's disease.

Villemagne VL, Rowe CC, Macfarlane S, Novakovic KE, Masters CL. Villemagne VL, et al. Among authors: rowe cc. J Clin Neurosci. 2005 Apr;12(3):221-30. doi: 10.1016/j.jocn.2004.03.011. J Clin Neurosci. 2005. PMID: 15851069 Review.

3

Simplified quantification of nicotinic receptors with 2[18F]F-A-85380 PET.

Mitkovski S, Villemagne VL, Novakovic KE, O'Keefe G, Tochon-Danguy H, Mulligan RS, Dickinson KL, Saunder T, Gregoire MC, Bottlaender M, Dolle F, Rowe CC. Mitkovski S, et al. Among authors: rowe cc. Nucl Med Biol. 2005 Aug;32(6):585-91. doi: 10.1016/j.nucmedbio.2005.04.013. Nucl Med Biol. 2005. PMID: 16026705

4

Rare genetically defined causes of dementia.

Novakovic KE, Villemagne VL, Rowe CC, Masters CL. Novakovic KE, et al. Among authors: rowe cc. Int Psychogeriatr. 2005;17 Suppl 1:S149-94. doi: 10.1017/s1041610205002012. Int Psychogeriatr. 2005. PMID: 16240489 Review.

5

Radioiodinated clioquinol as a biomarker for beta-amyloid: Zn complexes in Alzheimer's disease.

Opazo C, Luza S, Villemagne VL, Volitakis I, Rowe C, Barnham KJ, Strozyk D, Masters CL, Cherny RA, Bush AI. Opazo C, et al. Aging Cell. 2006 Feb;5(1):69-79. doi: 10.1111/j.1474-9726.2006.00196.x. Aging Cell. 2006. PMID: 16441845 Free article.

6

Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's disease.

Ng S, Villemagne VL, Berlangieri S, Lee ST, Cherk M, Gong SJ, Ackermann U, Saunder T, Tochon-Danguy H, Jones G, Smith C, O'Keefe G, Masters CL, Rowe CC. Ng S, et al. Among authors: rowe cc. J Nucl Med. 2007 Apr;48(4):547-52. doi: 10.2967/jnumed.106.037762. J Nucl Med. 2007. PMID: 17401090 Free article.

7

Imaging beta-amyloid burden in aging and dementia.

Rowe CC, Ng S, Ackermann U, Gong SJ, Pike K, Savage G, Cowie TF, Dickinson KL, Maruff P, Darby D, Smith C, Woodward M, Merory J, Tochon-Danguy H, O'Keefe G, Klunk WE, Mathis CA, Price JC, Masters CL, Villemagne VL. Rowe CC, et al. Neurology. 2007 May 15;68(20):1718-25. doi: 10.1212/01.wnl.0000261919.22630.ea. Neurology. 2007. PMID: 17502554

8

Evaluating atypical dementia syndromes using positron emission tomography with carbon 11 labeled Pittsburgh Compound B.

Ng SY, Villemagne VL, Masters CL, Rowe CC. Ng SY, et al. Among authors: rowe cc. Arch Neurol. 2007 Aug;64(8):1140-4. doi: 10.1001/archneur.64.8.1140. Arch Neurol. 2007. PMID: 17698704

9

In vitro characterization of Pittsburgh compound-B binding to Lewy bodies.

Fodero-Tavoletti MT, Smith DP, McLean CA, Adlard PA, Barnham KJ, Foster LE, Leone L, Perez K, Cortés M, Culvenor JG, Li QX, Laughton KM, Rowe CC, Masters CL, Cappai R, Villemagne VL. Fodero-Tavoletti MT, et al. Among authors: rowe cc. J Neurosci. 2007 Sep 26;27(39):10365-71. doi: 10.1523/JNEUROSCI.0630-07.2007. J Neurosci. 2007. PMID: 17898208 Free PMC article.

10

Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease.

Pike KE, Savage G, Villemagne VL, Ng S, Moss SA, Maruff P, Mathis CA, Klunk WE, Masters CL, Rowe CC. Pike KE, et al. Among authors: rowe cc. Brain. 2007 Nov;130(Pt 11):2837-44. doi: 10.1093/brain/awm238. Epub 2007 Oct 10. Brain. 2007. PMID: 17928318

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

459 results

Search Page

Filters